| Name | Ca x |
|---|---|
| Synonyms | CA X; CA RP X; CA RPX; CA10; CARP X; CARPX; Carbonic anhydrase X; Carbonic anhydrase related protein X… |
| Name | phosphorus |
|---|---|
| CAS | phosphorus |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 19473635 | Ito H, Ogata H, Yamamoto M, Takahashi K, Shishido K, Takahashi J, Taguchi S, Kinugasa E: Comparison of oral falecalcitriol and intravenous in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial. Clin Nephrol. 2009 Jun;71(6):660-8. Serum Ca, P, and Ca x P product levels at the end of each treatment were comparable and the frequencies of hypercalcemia and hyperphosphatemia were also similar during each treatment period. |
1(0,0,0,1) | Details |
| 20016142 | Lund RJ, Andress DL, Amdahl M, Williams LA, Heaney RP: Differential effects of paricalcitol and on intestinal absorption in hemodialysis patients. Am J Nephrol. 2010;31(2):165-70. Epub 2009 Dec 11. There were no significant differences in serum PTH, Ca, phosphorus (P), or Ca x P. |
0(0,0,0,0) | Details |
| 19736246 | Locatelli F, Dimkovic N, Pontoriero G, Spasovski G, Pljesa S, Kostic S, Manning A, Sano H, Nakajima S: Effect of MCI-196 on serum and levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study. Nephrol Dial Transplant. 2010 Feb;25(2):574-81. Epub 2009 Sep 7. However, -phosphorus product (Ca x P) was significantly reduced in the 6 and 9 g/day groups P < 0.05). |
112(1,2,2,2) | Details |
| 19713297 | Moore C, Yee J, Malluche H, Rao DS, Monier-Faugere MC, Adams E, Daramola-Ogunwuyi O, Fehmi H, Bhat S, Osman-Malik Y: Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients. Clin J Am Soc Nephrol. 2009 Sep;4(9):1484-1493. At the time of biopsy, mean corrected was 9.1, 8.9, and 9.4 mg/dl (P = 0.344); -phosphorus (Ca X PO4) product was 42, 55, and 62 mg (2)/dl (2) (P = 0.002); phosphorus was 4.6, 6.2, and 6.7 mg/dl (P = 0.005); and iPTH was 225, 566, and 975 pg/ml (P = 0.006), respectively. |
87(1,1,2,2) | Details |
| 19440993 | Petrovic D, Obrenovic R, Stojimirovic B: Risk factors for aortic valve calcification in patients on regular hemodialysis. Int J Artif Organs. 2009 Mar;32(3):173-9. The variables investigated were: serum albumin, C-reactive protein (CRP), total LDL- (LDL-C), HDL- (HDL-C), triglycerides (TG), Apolipoprotein A-I (Apo A-I), Apolipoprotein B (Apo B) and lipoprotein (a), and parathormone, and -phosphorus product (Ca x P). |
82(1,1,1,2) | Details |
| 19369690 | Urena P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S, Rix M, Os I, Saha H, Ryba M, Bencova V, Banos A, Zani V, Fouque D: Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study. Nephrol Dial Transplant. 2009 Sep;24(9):2852-9. Epub 2009 Apr 15. The proportions of patients achieving the recommended [NKF-K/DOQI (TM) (KDOQI (TM))] targets increased from baseline [4%, 39%, 40% and 46% for iPTH, phosphorus, and -phosphorus product (Ca x P), respectively] to Month 12 (28%, 48%, 51% and 68%, respectively). |
82(1,1,1,2) | Details |
| 19640383 | Liu YL, Wang SM, Lin HH, Wang IK, Kuo HL, Yang YF, Liu JH, Chou CY, Yeh HC, Ting IW, Tsai CA, Huang CC: The relationship between chronic hepatitis B infection and bone mineral, metabolism in peritoneal dialysis patients. Clin Nephrol. 2009 Jul;72(1):15-20. PATIENTS AND METHODS: Serum calcium [adj], phosphorus, and phosphorus product (Ca x P), along with intact parathyroid hormone (iPTH) levels were compared in peritoneal dialysis patients with and without chronic hepatitis B infection. |
81(1,1,1,1) | Details |
| 20167032 | Ashkar ZM: Association of -phosphorus product with blood pressure in dialysis. J Clin Hypertens. 2010 Feb 1;12(2):96-103. Linear regression analysis was done between averages of and phosphorus (ca x ph) product and blood pressures (BPs). |
33(0,1,1,3) | Details |
| 19298641 | Abdul Gafor AH, Saidin R, Loo CY, Mohd R, Zainudin S, Shah SA, Norella KC: Intravenous versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism. Nephrology. 2009 Aug;14(5):488-92. Epub 2009 Mar 10. Intensive treatment with is often complicated by hypercalcaemia, hyperphosphataemia and elevated phosphorus (Ca X PO (4)) product. |
32(0,1,1,2) | Details |
| 19713292 | Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Sanderson JE: Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?. Clin J Am Soc Nephrol. 2009 Oct;4(10):1629-36. Epub 2009 Aug 27. Using multiple linear regression analysis, loss of RRF showed significant association with increased LV mass index, but this association was lost after additional adjustment for CRP, Ca x P, and valvular calcification. |
2(0,0,0,2) | Details |
| 19808245 | Navarro-Gonzalez JF, Mora-Fernandez C, Muros M, Herrera H, Garcia J: Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. Clin J Am Soc Nephrol. 2009 Oct;4(10):1646-54. Epub 2009 Sep 24. After adjustment for age, gender, and eGFR, the levels of C-reactive protein (CRP) and IL-6 (IL-6) of the third tertile of P, Ca x P, and PTH were significantly higher than those of the first and second tertiles. |
2(0,0,0,2) | Details |
| 19297359 | Davidovich E, Davidovits M, Peretz B, Shapira J, Aframian DJ: The correlation between dental calculus and disturbed mineral metabolism in paediatric patients with chronic kidney disease. Nephrol Dial Transplant. 2009 Aug;24(8):2439-45. Epub 2009 Mar 17. The lowest salivary Mg was found in the D group while the highest salivary Ca x P product was found in the PrD group. |
1(0,0,0,1) | Details |
| 19762837 | Moreira VR, Zeringue LK, Williams CC, Leonardi C, McCormick ME: Influence of and phosphorus feeding on markers of bone metabolism in transition cows. J Dairy Sci. 2009 Oct;92(10):5189-98. concentrations were affected by dietary Ca levels and tended to have a significant dietary Ca x dietary P interaction. |
1(0,0,0,1) | Details |